Quality of Life in Patients Receiving Medical Cannabis

Quality of Life in Patients Receiving Medical Cannabis


Lliana Tsampoula, Afroditi Zartaloudi, Evangelos Dousis, Ioannis Koutelekos, Niki Pavlatou, Georgia Toulia, Antonia Kalogianni & Maria Polikandrioti


August 16, 2023


Introduction: Medical cannabis has been used to relieve the symptoms of people with various chronic diseases. Despite of this, it has been stigmatized, even after its legalization in many countries.

Aim: The purpose of this study was to investigate the quality of life of patients receiving medical cannabis. Material and method: One hundred patients receiving medical cannabis were given (a) a socio-demographic and clinical questionnaire, and (b) the SF-36 Health Survey scale for assessing quality of life.

Results: The majority of our patients who received medical cannabis to treat their neurological disorders (58%) reported decrease in their symptoms (96%), better energy and vitality (68%), ability to perform their professional duties (88%), and an improvement in sleeping and appetite (79% and 71%, respectively) after receiving medical cannabis. Our participants exhibited very few restrictions in activities due to emotional difficulties, a moderate general health status as well as moderate vitality and energy. Participants, who reported a longer period of receiving medical cannabis, reported statistically significant more energy and vitality (p = 0.000), but also better mental (p = 0.000) and general health status (p = 0.001). Furthermore, the majority of patients have disclosed medical cannabis use to their family members (85%) and enjoyed their support (93%), but they haven’t revealed their medication treatment to their social environment (81%).

Conclusions: Appropriate knowledge could significantly help health professionals in the field of planning and implementation of personalized nursing care in order to achieve optimal therapeutic outcomes.

DOI: 10.1007/978-3-031-31986-0_39


Tsampoula, I., Zartaloudi, A., Dousis, E., Koutelekos, I., Pavlatou, N., Toulia, G., … & Polikandrioti, M. (2022, October). Quality of Life in Patients Receiving Medical Cannabis. In Worldwide Congress on “Genetics, Geriatrics and Neurodegenerative Diseases Research” (pp. 401-415). Cham: Springer International Publishing.